Evidence map›Paper›PMID 31234013›Full record

Trial reportDrug and alcohol dependence2019

The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection.

Jennifer C Elliott, Lacey Critchley, Daniel J Feaster, Deborah S Hasin, Raul N Mandler, Georgina Osorio, Allan E Rodriguez, Carlos Del Rio, Lisa R Metsch

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jennifer C ElliottDepartment of Psychiatry, Columbia University Medical Center, 1051 Riverside Drive, Box 123, New York, NY, 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, Box 123, New York, NY, 10032, USA. Electronic address: Jce2130@cumc.columbia.edu.
Lacey CritchleyDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, 1120 N.W. 14th Street, Miami, Florida, 33136 USA.
Daniel J FeasterDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, 1120 N.W. 14th Street, Miami, Florida, 33136 USA.
Deborah S HasinDepartment of Psychiatry, Columbia University Medical Center, 1051 Riverside Drive, Box 123, New York, NY, 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, Box 123, New York, NY, 10032, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168(th) St, New York, NY, 10032, USA.
Raul N MandlerCenter for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Blvd, Bethesda, MD 20952, Room B1-W30, Bethesda, MD, USA.
Georgina OsorioMount Sinai St. Luke's and Mount Sinai West, Icahn School of Medicine at Mount Sinai, 440 West 114th Street, 6th floor (Clark Building), New York, NY, 10025, USA.
Allan E RodriguezDivision of Infectious Diseases, Miller School of Medicine, University of Miami, 1120 NW 14th Street Suite 856, Miami, FL, 33136, USA.
Carlos Del RioEmory University School of Medicine, Atlanta, GA, USA.
Lisa R MetschDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 W 168(th) St, New York, NY, 10032, USA.
University of Miami · USColumbia University · USColumbia University Irving Medical Center · USEmory University · USIcahn School of Medicine at Mount Sinai · USNational Institute on Drug Abuse · USNew York State Psychiatric Institute

Funding

FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependenceR01AA023163 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2014 to 2018
$3.5M
Understanding and intervening with heavy drinking among patients with HIV and HCVK23AA023753 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ELLIOTT, JENNIFER CHRISTINE · 2015 to 2019
$972k
NIAAA NIH HHS K23 AA023753NIAAA NIH HHS R01 AA023163NIDA NIH HHS U10 DA013720NIDA NIH HHS UG1 DA013720
6 · The paper itself

Abstract

backgroundSubstance use can reduce care engagement for individuals with HIV. However, little is known as to whether heavy drinkers differ from drug users. This study compares heavy drinkers, drug users, and those drinking heavily and using drugs on their HIV care engagement.

methodsHIV-infected adult inpatients (n = 801; 67% male; 78% Black) from 11 urban hospitals across the United States participated in a multisite clinical trial to improve patient engagement in HIV care and virologic outcomes. All participants drank heavily and/or used drugs, and had poorly controlled HIV. Participants reported care history at baseline. We compared heavy drinkers, drug users, and those both drinking heavily and using drugs (reference group) on their engagement in care.

resultsHeavy drinkers reported lowest rates of lifetime HIV care, AOR = 0.59 (95% CI = 0.36, 0.97). Groups did not differ in recent care, prescription of HIV medication, medical mistrust, or patient-provider relationship. Drug users evidenced the best medication adherence, AOR = 2.38 (95% CI = 1.33, 4.23). Exploratory analyses indicated that drinkers had lower initial care engagement, but that it increased more rapidly with duration of known HIV infection, with similar rates of recent care. Drinkers had the lowest CD4 counts (B=-0.28, p < 0.0001), but no difference in viral load.

conclusionsHeavy drinkers were least likely to have ever been in HIV care. More research is needed to determine why heavy drinkers evidence the lowest initial care engagement and current CD4 counts, and whether drinking intervention early in infection may increase HIV care engagement.

Indexed as

HospitalizationAdultAlcoholic IntoxicationCross-Sectional StudiesDrug UsersFemaleHIV InfectionsHumansMaleMedication AdherenceMiddle AgedPatient ParticipationSubstance-Related DisordersUnited StatesViral LoadYoung AdultAlcoholCare engagementDrugHIVTreatment

Identifiers

PMID31234013
PMCPMC6677390
OpenAlexW2948099137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.